bio-equity
341 posts

bio-equity retweetledi
bio-equity retweetledi

Mylan turns screws on Pfizer over EpiPen shortage; sends crack team to troubled St Louis factory to try to fix manufacturing issues. $Myl $pfe twitter.com/financialtimes…
Financial Times@FinancialTimes
Pfizer under pressure to resolve shortage of life-saving EpiPen on.ft.com/2IFn3iI
English
bio-equity retweetledi
bio-equity retweetledi
bio-equity retweetledi
bio-equity retweetledi
bio-equity retweetledi
bio-equity retweetledi
bio-equity retweetledi

@adamfeuerstein Yes lets run a placebo arm with a condition that has a higher mortality rate than pancreatic cancer. Brilliant analysis, Adam
English
bio-equity retweetledi

$VBLT Receives undisclosed Milestone Payment From NanoCarrier Under Licensing Agreement for VB-111 in Japan finance.yahoo.com/news/vbl-thera…
English
bio-equity retweetledi

Here's Bristol's press release. This news on the TMB biomarker is potentially a very important finding for immunotherapy, if true. This will have been an important study result for that reason alone. investors.bms.com/iframes/press-…
English

@adamfeuerstein Not new or news at all. In fact its the same old pump from you where we have known about them targeting a larger percentage for some time. I assume the $VRTX checks keep coming, eh Adam? Hard to turn down on your salary I suppose
English
bio-equity retweetledi

BREAKING: Berkshire Hathaway, Amazon, and JPMorgan Chase partner on health care for their US employees through creation of “an independent company that is free from profit-making incentives and constraints” cnbc.com/2018/01/30/ama…
English
bio-equity retweetledi

This is really cool: $MRK spinout grabs some assets and launches a quest for the Holy Grail in antibiotics R&D - endpts.com/merck-spinout-… by @JohnCEndpts
English
bio-equity retweetledi
bio-equity retweetledi

The float already scares me on $SGYP. I am staying away twitter.com/shaneblackmon/…
English






